OTC:RSMDF

ResMed Elects Karen Drexler to Its Board of Directors

A champion of women in leadership, Drexler brings wealth of experience at both commercial-stage and start-up medtech and healthcare companies Also at annual meeting of shareholders, long-serving Director Chris Roberts announced his retirement SAN DIEGO, Nov. 17, 2017 /PRNewswire/ -- ResMed (NYS...

2017-11-17 22:00 931

Statement by ResMed on United Kingdom Case with Fisher & Paykel

SAN DIEGO, Nov. 13, 2017 /PRNewswire/ -- ResMed (NYSE: RMD, ASX: RMD) today issued the following statement fromDavid Pendarvis, the company's global general counsel and chief administrative officer: Logo - https://mma.prnewswire.com/media/588826/RESMED_INC__LOGO.jpg

2017-11-13 09:51 754

ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP

ResMed's AirMini now cloud-connects to HMEs through AirView remote monitoring SAN DIEGO, Nov. 6, 2017 /PRNewswire/ -- ResMed (NYSE: RMD, ASX: RMD) today announced that AirMini, the world's smallest PAP (positive airway pressure) device, is now connected to AirView, the world's largest remote pati...

2017-11-06 22:00 733

ResMed Wins German Patent Infringement Case Brought by Fisher & Paykel

ResMed's AirSense 10, AirCurve 10 and Lumis products do not infringe German utility model patent MUNICH, Oct. 12, 2017 /PRNewswire/ -- ResMed (NYSE: RMD), the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced that...

2017-10-12 22:12 792

ResMed's European Patents Infringed by Fisher & Paykel in Germany

-- German court concludes that Fisher & Paykel Simplus, Eson and Eson 2 masks infringe two ResMed European patents.  -- ResMed will now defend those patents before the European Patent Office. -- Fisher & Paykel required to pay ResMed court costs in Australian patent suit. SAN DIEGO, Oct. 6, ...

2017-10-06 17:36 757

Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel

SAN DIEGO, May 17, 2017 /PRNewswire/ -- ResMed today issued the following statement fromDavid Pendarvis, the company's global general counsel and chief administrative officer: Experience the interactive Multimedia News Release here: https://www.multivu.com/players/English/74629527-resmed-patent-...

2017-05-17 16:22 1842

ResMed Unveils AirMini - the World's Smallest CPAP

Sleek product design and engaging smartphone app revolutionizes CPAP experience for the world's 100 million sleep apnea sufferers SAN DIEGO, April 25, 2017 /PRNewswire/ -- ResMed (NYSE: RMD) today unveiled its AirMini™, the world's smallest CPAP machine – a game-changer for people with sleep ap...

2017-04-25 21:39 1695

New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea

- Largest-ever analysis of patients with treatment-emergent central sleep apnea shows switching from CPAP to ASV significantly improves compliance - Study highlights the need to consider therapeutic options based on each patient's disease severity MARSEILLES, France, April 6, 2017 /PRNewswire/ -...

2017-04-06 21:00 2116

ResMed Named Global Leader in Remote Patient Monitoring

SAN DIEGO, Feb. 13, 2017 /PRNewswire/ -- ResMed's global lead in remote patient monitoring kept growing in 2016, even as the industry itself continued to expand, according to the annual mHealth & Home Monitoring report released by independent technology analyst firm Berg Insight. Logo - http://m...

2017-02-13 22:00 1514

ResMed and BMC/3B Medical Settle Global Litigation

SAN DIEGO, Jan. 23, 2017 /PRNewswire/ -- ResMed (NYSE: RMD), BMC (Beijing, China ) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted to sell their existing products in exchange for roya...

2017-01-23 18:00 1908

ResMed and BMC/3B Medical Settle Global Litigation

SAN DIEGO, Jan. 21, 2017 /PRNewswire/ -- ResMed (NYSE:RMD), BMC (Beijing, China ) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted to sell their existing products in exchange for royal...

2017-01-21 07:06 4080

ResMed Reaches Historic One Billionth Night of Sleep Monitored

- World's largest repository of sleep data -- a giant step forward for sleep medicine - Predictive analytics from data will improve therapy and outcomes for sleep patients - Milestone reinforces ResMed's leadership in remote patient monitoring industry SAN DIEGO, Jan. 4, 2017 /PRNewswire/ -- R...

2017-01-04 22:00 1232

ResMed Appoints Carlos Nunez, MD, as Chief Medical Officer

SAN DIEGO, Dec. 20, 2016 /PRNewswire/ -- ResMed (NYSE: RMD) today announced that industry leaderCarlos M. Nunez, MD, will become ResMed's chief medical officer, effectiveJanuary 3, 2017. Logo - http://mma.prnewswire.com/media/450864/resmed_Logo.jpg

2016-12-20 22:00 1541

ResMed Launches AirView Action Groups, the Ultimate Time-saver For Home Medical Equipment Providers

ATLANTA, Nov. 1, 2016 /PRNewswire/ -- ResMed (NYSE:RMD) today announced two enhancements to AirView™, the world's largest cloud-based remote patient monitoring platform that enables care teams to securely access therapy data from three million sleep apnea and respiratory care patients every day. ...

2016-11-01 21:05 1255

ResMed Introduces AirFit(TM) N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort

ATLANTA, Nov. 1, 2016 /PRNewswire/ -- ResMed (NYSE:RMD) today introduced the AirFit N20 nasal mask and AirFit F20 full face mask for positive airway pressure (PAP) treatment of sleep apnea. Loaded with innovations designed to improve mask fit, comfort and ease of use, the new-generation ResMed ma...

2016-11-01 21:00 1441

Results from World's Largest Study on Sleep Apnea and Digital Connected Care

LOS ANGELES, Oct. 25, 2016 /PRNewswire/ -- In a new research study being presented tomorrow at the CHEST 2016 annual meeting, ResMed (NYSE: RMD) will share evidence that people who use a self-management app when treating their sleep apnea with positive airway pressure (PAP) are significantly more...

2016-10-25 21:00 1218

Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System

MOUNTAIN VIEW, Calif., Oct. 14, 2016 /PRNewswire/ -- Based on its recent analysis of the sleep tracking solutions market, Frost & Sullivan recognizes ResMed with the 2016 North American Product Leadership Award for sleep tracking solutions. ...

2016-10-14 21:00 1796

ResMed Takes Fisher & Paykel to Court over Patents

SAN DIEGO, Aug. 18, 2016 /PRNewswire/ -- ResMed (NYSE: RMD), the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, announced today it has filed legal actions with the United States International Trade Commission, the United ...

2016-08-18 05:46 1648

ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical

SAN DIEGO, July 31, 2015 /PRNewswire/ -- ResMed (NYSE:RMD) today announced it has signed a definitive agreement to acquire Curative Medical, a privately-held leading provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories. "Curative's strong clinical, ...

2015-07-31 04:02 2658

ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure

SAN DIEGO, May 13, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced that SERVE-HF, a multinational, multicenter, randomized controlled Phase III trial did not meet its primary endpoint.  SERVE-HF was designed to assess whether the treatment of moderate to severe predominant central sleep a...

2015-05-13 16:04 2138
12